News | October 12, 2025
Samsung Biologics introduces optimized manufacturing framework ‘ExellenS’
ExellenS applies optimized facility designs, equipment, and processes across all sites to ensure equivalency and speed
ExellenS applies optimized facility designs, equipment, and processes across all sites to ensure equivalency and speed
New filling line approval supports delivery of integrated, end-to-end solutions across the entire biologics and bioconjugates value chain
Lonza boosts TheraPEAK line with new Cytokines and AAV Medium for next-gen therapies
With global certification in place, the Ambernath site expands Supriya’s footprint beyond APIs into high-margin formulations
Represents one of the largest cell culture biomanufacturing sites in North America, which will employ 1,400 people by 2031
ProBioGen will oversee the design, construction, and operation of the 4,600-square-meter GMP manufacturing unit
The Ma’anshan site approval covers pastilles, oral liquids, and powders
Kenox to provide formulation and development expertise in orally inhaled and nasal drug products
WIDAPLIK is the first and only FDA-approved triple combination medication for use as an initial therapy in patients likely to need multiple drugs to achieve blood pressure goals
Subscribe To Our Newsletter & Stay Updated
